Combined impacts of low apolipoprotein A-I levels and reduced renal function on long-term prognosis in patients with coronary artery disease undergoing percutaneous coronary intervention.
All-cause death
Apolipoprotein A-I
Cardiovascular events
Kidney disease
Long-term prognosis
Percutaneous coronary intervention
Journal
Clinica chimica acta; international journal of clinical chemistry
ISSN: 1873-3492
Titre abrégé: Clin Chim Acta
Pays: Netherlands
ID NLM: 1302422
Informations de publication
Date de publication:
01 Nov 2022
01 Nov 2022
Historique:
received:
11
08
2022
revised:
14
09
2022
accepted:
20
09
2022
pubmed:
7
10
2022
medline:
20
10
2022
entrez:
6
10
2022
Statut:
ppublish
Résumé
The relationship of apolipoprotein A-I (ApoA-I) and renal function in patients after intervention remain unclear, thus, we aimed to evaluate the combined impacts of ApoA-I and kidney disease (K Altogether, 4101 consecutive patients who underwent intervention between 2000 and 2016 were included. The patients were divided into four groups based on the median ApoA-I values and presence of K During the median follow-up period of 6.2 years, 618 patients (15.1%) developed MACCE, and 627 patients (15.3%) died. ApoA-I level was significantly related to estimated glomerular filtration rate, and ApoA-I levels and K The combined impacts of ApoA-I and renal function could be useful for evaluating cardiovascular and life prognoses in patients undergoing intervention.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
The relationship of apolipoprotein A-I (ApoA-I) and renal function in patients after intervention remain unclear, thus, we aimed to evaluate the combined impacts of ApoA-I and kidney disease (K
MATERIAL AND METHODS
METHODS
Altogether, 4101 consecutive patients who underwent intervention between 2000 and 2016 were included. The patients were divided into four groups based on the median ApoA-I values and presence of K
RESULTS
RESULTS
During the median follow-up period of 6.2 years, 618 patients (15.1%) developed MACCE, and 627 patients (15.3%) died. ApoA-I level was significantly related to estimated glomerular filtration rate, and ApoA-I levels and K
CONCLUSION
CONCLUSIONS
The combined impacts of ApoA-I and renal function could be useful for evaluating cardiovascular and life prognoses in patients undergoing intervention.
Identifiants
pubmed: 36202225
pii: S0009-8981(22)01318-3
doi: 10.1016/j.cca.2022.09.020
pii:
doi:
Substances chimiques
Apolipoprotein A-I
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
180-190Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.